All Stories

  1. Lessons from developing, implementing and sustaining the first stroke unit in Malawi
  2. Long-term antithrombotic therapy after carotid endarterectomy for symptomatic carotid disease: an international survey of practice patterns, guideline concordance and trial readiness for dual pathway inhibition
  3. Peri-operative Outcomes after Carotid Endarterectomy in Selected Operated Patients with Pre-operative Modified Rankin Scale Score 3: Analysis of the UK National Vascular Registry
  4. SRS172 - Adherence to local guidelines for antiplatelet therapy after symptomatic carotid endarterectomy: a global survey
  5. SRS173 - The impact of preexisting atrial fibrillation on early outcomes following symptomatic carotid endarterectomy: a national analysis of 17 440 cases
  6. SRS326 - How accurately can carotid body tumours be distinguished from nerve neck paraganglionomas on imaging? An audit
  7. Case report: a rare case of left-sided sinus of Valsalva aneurysm with concomitant coronary artery fistula and carotid artery aneurysm
  8. A systematic review and meta-analysis of the late causes of death following successful carotid endarterectomy (CEA)
  9. 156 Carotid endarterectomy in the era of optimum medical therapy – is it becoming a relic?
  10. 37 Does modified Rankin Score Matter? A five-year retrospective analysis of the National Vascular Registry to assess the impact of stroke severity on carotid artery endarterectomy outcomes
  11. 82 Would Vascular surgeon adopt the COMPASS as their post-carotid endarterectomy (CEA) long-term antithrombotic drug regimen?
  12. Patient Acceptance and Adherence to the COMPASS Trial Drug Recommendations Following Symptomatic Carotid Endarterectomy
  13. Hyperhidrosis
  14. Acceptance and Adherence to the COMPASS Trial Drug Recommendations Following Symptomatic Carotid Endarterectomy (CEA)
  15. Long-term Drug therapy following Carotid endarterectomy aimed at reducing Major Adverse Cardiovascular Events
  16. O36: Patient acceptability and adherence to the COMPASS trial drug recommendations following symptomatic carotid endarterectomy (CEA)
  17. O68: Long term stroke prevention drug therapy following Carotid endarterectomy (CEA) is good, but could be better
  18. An Analysis of Cost-Effectiveness and Clinical Outcomes of a Comprehensive Aortic Service in a Tertiary Center over One Year
  19. Chemotherapy Emboli as an Iatrogenic Cause of Ischaemic Stroke Arising from a Misplaced Central Venous Access Line
  20. Does Modified Rankin Score (mRS) Matter? The Impact of Stroke Severity on Carotid Artery Endarterectomy (CEA) Outcomes
  21. A Retrospective Cohort Study of Cerebrovascular Fibromuscular Dysplasia
  22. O065 Does modified Rankin score (mRS) matter? the impact of stroke severity on carotid endarterectomy (CEA) outcomes
  23. An Analysis of Cost Effectiveness and Clinical Outcomes of a Comprehensive Aortic Service in a Tertiary Centre Over One Year
  24. P18 Components of the ideal spoke vascular surgery unit
  25. O059 Introduction of the SHOUT protocol in the early post-operative period following carotid surgery
  26. Infective Native Extracranial Carotid Artery Aneurysms: A Systematic Review
  27. Identification of Surgeon Burnout via a Single-Item Measure
  28. A Stepwise Haemostasis Intraoperative Protocol Driven Reduction of Haematoma Rate Following Symptomatic Carotidendarterectomy
  29. 987 Protocol Driven Reduction of Haematoma Following Symptomatic Carotid Endarterectomy (CEA) – a Prospective Cohort Study
  30. EP-681 Adherence to VTE prophylaxis guidelines in general surgical patients: a single-centre study
  31. P10 Adherence to vte prophylaxis guidelines in general surgical patients: a single-centre study
  32. P20 Pre-operative checklist to improve pathway for carotid endarterectomy (CEA) patients: a single centre audit
  33. O011 An analysis of cost effectiveness and clinical outcomes of elective abdominal aortic aneursym repair in a tertiary centre over one year
  34. O070 Can the compass trial recommendations be implemented following symptomatic carotid endarterectomy (CEA)?
  35. O065 Mycotic extracranial carotid artery aneurysms: a systematic review
  36. O058 Characteristics and prognosis of cerebrovascular fibromuscular dysplasia (FMD) - a retrospective cohort study
  37. Mycotic internal carotid artery pseudoaneurysm secondary to Mycobacterium tuberculosis
  38. An Analysis of Cost Effectiveness and Clinical Outcomes of Elective Abdominal Aortic Aneurysm Repair in a Tertiary Centre Over One Year
  39. Characteristics and Prognosis of Cerebrovascular Fibromuscular Dysplasia—A Retrospective Cohort Study
  40. Mycotic Extracranial Carotid Artery Aneurysms: A Systematic Review
  41. Hyperhidrosis
  42. A Stepwise Protocol to Reduce Haematoma Rates in Carotid Endarterectomy
  43. Abstracts From the Neuro Anaesthesia and Critical Care Society Virtual Annual Scientific Meeting: Leeds, May 13 to 14, 2021
  44. Burnout Among Surgeons in the UK During the COVID-19 Pandemic: A Cohort Study
  45. BJS commission on surgery and perioperative care post-COVID-19
  46. Transmission of infection among health care personnel performing surgical tracheostomies on COVID-19 patients
  47. 213 Can Styloid Process and Internal Carotid Artery Anatomy Be Used to Predict Carotid Artery Dissection?
  48. Aberrant right subclavian artery – a rare congenital anatomical variation causing dysphagia lusoria
  49. Can Styloid Process and Internal Carotid Artery Anatomy be Used to Predict Carotid Artery Dissection?
  50. O28 Can styloid process and internal carotid artery anatomy be used to predict carotid artery dissection?
  51. O47 Safe delivery of surgical tracheostomies in COVID-19 patients during the pandemic
  52. O37 Carotid surgery during the COVID-19 pandemic
  53. Dual-modality emergency management of a rare cause of an aorto-oesophageal fistula: a case report
  54. SARS-CoV-2 and Pre-existing Vascular Diseases: Guilt by Association?
  55. A systematic review and meta‐analysis of outcomes after elective surgery for ulcerative colitis
  56. Why are more otorhinolaryngology surgeons dying from Covid-19 than any other surgical specialty?
  57. Hyperglycaemia and Ischaemia Impair Wound Healing via Toll-like Receptor 4 Pathway Activation in vitro and in an Experimental Murine Model
  58. Hyperglycaemia and Ischaemia Impair Wound Healing via Toll-like Receptor 4 Pathway Activation in vitro and in an Experimental Murine Model
  59. Accuracy of Realtime Overlay for Aneurysm Repair in Awake Patients
  60. Toll-like receptors 2 and 6 mediate apoptosis and inflammation in ischemic skeletal myotubes
  61. Poster presentations
  62. Abstract 130: Exosomal Cellular Communication in Peripheral Arterial Disease
  63. Screening Programs for Abdominal Aortic Aneurysms: Luxury or Necessity?
  64. Treatment of primary hyperhidrosis with oral anticholinergic medications: a systematic review
  65. Role of surgical thoracic sympathetic interruption in treatment of facial blushing: a systematic review
  66. Topical glycopyrrolate reduces axillary hyperhidrosis to a similar extent as subcutaneous Botox injections
  67. Topical glycopyrrolate reduces axillary hyperhidrosis
  68. Evidence based management of craniofacial hyperhidrosis: A systematic review
  69. The innate immune system, toll-like receptors and dermal wound healing: A review
  70. Treatment of Primary Craniofacial Hyperhidrosis: A Systematic Review
  71. Resection of a large carotid paraganglioma in Carney-Stratakis syndrome: a multidisciplinary feat
  72. Carney-Stratakis Syndrome Caused by a Novel SDHD Mutation
  73. Critical Limb Ischaemia in Adult Human Skeletal Muscle Increases Satellite Cell Proliferation but Not Differentiation
  74. Potential role of erythropoietin receptors and ligands in attenuating apoptosis and inflammation in critical limb ischemia
  75. Hyperglycaemia Exaggerates Ischaemia Induced Tissue Damage in Dermal Fibroblasts Through MyD88 Dependant Toll-like Receptor 4 Activation
  76. The Role of Erythropoietin in Skeletal Muscle Ischaemia In Vitro and In Vivo
  77. Abstract 148: Critical Role of Toll-Like Receptor 4 in Ischemia-Induced Skeletal Muscle Damage
  78. Abstract 210: Hyperglycemia Results in an Exaggerated Response to Ischemia in Human Dermal Fibroblasts Through MyD88 Dependant Toll-Like Receptor 4 Activation
  79. Abstract 44: Tissue-Protective Effects of an Erythropoietin Derivative in in vitro and in vivo Models of Skeletal Muscle Ischemia
  80. Who’s trusting in a truss?
  81. Stem cells of the lower limb: Their role and potential in management of critical limb ischemia
  82. Detrimental Role of Heat Shock Protein 60&70 and Toll-like Receptor 4 in Skeletal Muscle Ischaemia In Vitro
  83. Differential Proliferative and Migratory Activity of Human Myoblasts Isolated from CLI and Control Patients
  84. Signalling Pathways Involved in the Tissue-protective Effects of Erythropoietin and Erythropoietin-derivatives in Ischemic Human Myotubes
  85. Abstract 197: Emerging Role of Toll-like Receptor 4 and Heat Shock Protein 60&70 in Ischaemia-Induced Skeletal Muscle Damage In Vitro
  86. Abstract 255: Cytoprotective Effects of Erythropoietin and Erythropoietin-derivatives in Ischaemic Human Myotubes and the Role of Pi3k/akt Signalling Pathway
  87. Abstract 288: Differences in Proliferative and Migratory Capability of Human Myoblasts Isolated From CLI and Control Patients
  88. Functional up-regulation of toll-like receptor 4 and 1 in ischaemic skeletal muscle
  89. IGF-1 has no effect on the proliferation or differentiation of myoblasts exposed to ischaemic conditions
  90. Toll-like receptor (TLR) 2 and 6 ligands and heat shock proteins 60 and 70 may play a role in the pathogenesis of skeletal muscle damage in critical limb ischaemia
  91. Therapeutic role of toll-like receptor modification in cardiovascular dysfunction
  92. Kirk's General Surgical Operations
  93. Arteries
  94. Sympathectomy and the management of hyperhidrosis
  95. Preface
  96. Veins and lymphatics
  97. Abdominal wall and hernias
  98. Appraisal and revalidation
  99. PS182. Skeletal Muscle Damage in Critical Limb Ischemia (CLI) Is Mediated via the MyD88-Dependent Signalling Pathway
  100. PS190. Ischemia Mediates Myogenic Progenitor Cell Dysfunction
  101. PS194. Role of PI3k/Akt Pathway in the Cytoprotective Effects of Erythropoietin and Derivatives in Ischemic Human Myotubes
  102. Abstract 146: Activation of the Toll-like Receptor (TLR) Adapter Protein MyD88 Is Detrimental to Skeletal Muscle in Critical Limb Ischemia (CLI)
  103. Abstract 123: Ischemia Mediates Myogenic Progenitor Cell Dysfunction
  104. Abstract 278: Signaling Pathways Involved in the Cytoprotective Effects of Erythropoietin and Erythropoietin Derivatives in Ischemic Human Myotubes
  105. Haemophilic pseudotumour of the carotid artery
  106. Nitric Oxide Manipulation: A Therapeutic Target for Peripheral Arterial Disease?
  107. Potential of Novel EPO Derivatives in Limb Ischemia
  108. Stromal-Cell-Derived Factor-1 (SDF-1)/CXCL12 as Potential Target of Therapeutic Angiogenesis in Critical Leg Ischaemia
  109. Toll-Like Receptors in Ischaemia and Its Potential Role in the Pathophysiology of Muscle Damage in Critical Limb Ischaemia
  110. Cell Signalling Pathways Leading to Novel Therapeutic Strategies in Cardiovascular Disease
  111. Carotid body tumours
  112. Development of an in vitro model of myotube ischemia
  113. PS194. Role of Erythropoietin Receptors and Ligands in Attenuating Inflammation and Apoptosis in Critical Limb Ischemia
  114. PS204. The Toll-like Receptor 2 Ligand HMGB-1 Contributes to Skeletal Muscle Damage in Critical Limb Ischemia
  115. Critical limb ischemia classification and therapeutic angiogenesis
  116. Aortic Tumor Presenting as Acute Lower Limb Ischemia
  117. Isolated Endarterectomy of Femoral Bifurcation in Critical Limb Ischemia: Is Restoration of Inline Flow Essential?
  118. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial
  119. PS140. Isolated Endarterectomy of Femoral Bifurcation in Critical Limb Ischemia (CLI): Is Restoration of Inline Flow Essential?
  120. MS150 BASEMENT MEMBRANE ADAPTATIONS IN CRITICAL LIMB ISCHAEMIA
  121. PS148. Long-term Outcome After Surgical Intervention for Common Femoral Artery (CFA) Occlusive Disease
  122. Review of the Role of Erythropoietin in Critical Leg Ischemia
  123. Angiogenic effects of stromal cell-derived factor-1 (SDF-1/CXCL12) variants in vitro and the in vivo expressions of CXCL12 variants and CXCR4 in human critical leg ischemia
  124. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial
  125. Endovascular Aortic Aneurysm Repair (EVAR) Has Significantly Lower Perioperative Mortality in Comparison to Open Repair: A Systematic Review
  126. Does Diabetes Mellitus Play a Role in Restenosis and Patency Rates Following Lower Extremity Peripheral Arterial Revascularization? A Critical Overview
  127. Le diabète joue-t-il un rôle dans les resténoses et les taux de perméabilité après revascularisation artérielle des membres inferieurs ? une étude générale critique
  128. ¿Qué papel desempeña la diabetes mellitus en las tasas de reestenosis y permeabilidad tras la revascularización infrainginal? Revisión crítica
  129. Bypass surgery for chronic lower limb ischaemia
  130. Splenic trauma during abdominal wall liposuction: a case report
  131. Functional outcome after femoral endarterectomy: A single-centre experience
  132. The role of fibrinogen and fibrinolysis in peripheral arterial disease
  133. Varicose veins
  134. Impact of rapid molecular screening for meticillin-resistant Staphylococcus aureus in surgical wards
  135. A cheap soundbite
  136. Single-Center Experience of Endovascular Abdominal Aortic Aneurysm Repair (EVAR) in Patients Not Participating in the U.K. EVAR Trials
  137. Alterations in Nitric Oxide Synthase Isoforms in Acute Lower Limb Ischemia and Reperfusion
  138. Nitric oxide synthase in critically ischaemic muscle and alterations in isoform expression during revascularization surgery
  139. A Multicenter Review of Carotid Body Tumour Management
  140. Applicability of Glasgow Aneurysm Score and Hardman Index to Elective Endovascular Abdominal Aortic Aneurysm Repair
  141. Alterations in Purinoceptor Expression in Human Long Saphenous Vein during Varicose Disease
  142. Alterations in Purinoceptor Expression in Human Long Saphenous Vein during Varicose Disease
  143. Upper Limb Deep Vein Thrombosis: A Literature Review to Streamline the Protocol for Management
  144. Stroke Prevention in Clinical Practice
  145. Knee versus Thigh Length Graduated Compression Stockings for Prevention of Deep Venous Thrombosis: A Systematic Review
  146. Knee versus Thigh Length Graduated Compression Stockings for Prevention of Deep Venous Thrombosis: A Systematic Review
  147. Hypoxia-Inducible Factor 1 in Lower Limb Ischemia
  148. Purinoceptor expression on keratinocytes reflects their function on the epidermis during chronic venous insufficiency
  149. Increased angiogenic response but deficient arteriolization and abnormal microvessel ultrastructure in critical leg ischaemia
  150. Angiogenic roles of stromal-derived factor-1(SDF-1/CXCL12) variants and in-vivo CXCR4 expression in microvessels of human critical limb ischaemia
  151. Increased angiogenic response but deficient arteriolization and abnormal microvessel ultrastructure in human critical limb ischaemia
  152. Endothelin-1 promotes proliferation and angiogenesis in cultured endothelial cells via the ETB receptor
  153. Increased endogenous angiogenic response and hypoxia-inducible factor-1α in human critical limb ischemia
  154. Pulmonary thromboembolism in Klippel–Trenaunay–Weber syndrome – should all cases be anticoagulated?
  155. Mesenteric ischaemia
  156. Vascular injuries of the limbs
  157. Critical limb ischemia classification and therapeutic angiogenesis
  158. A Review of Methods Currently Used for Assessment of In vivo Endothelial Function
  159. How do we assess microsurgical skill?
  160. Varicose veins
  161. Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: A randomized controlled trial of intravenous N-acetylcysteine
  162. Achieving compliance with the European Working Time Directive in a large teaching hospital: a strategic approach
  163. Altered Endothelin-1 Levels in Acute Lower Limb Ischemia and Reperfusion
  164. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial
  165. Effect of Graduated Compression Stockings on Limb Oxygenation and Venous Function during Exercise in Patients with Venous Insufficiency
  166. The Role of Percutaneous Transluminal Angioplasty in the Treatment of Carotid Fibromuscular Dysplasia
  167. Evidence for the involvement of endothelin-1 but not urotensin-II in chronic lower limb ischaemia in man
  168. True juxta-anastomotic aneurysms in the residual infra-renal abdominal aorta
  169. Nicotine Abolishes the Hypoxic Induction of Vegf in Human Microvascular Endothelial Cells
  170. Effect of Graduated Compression Stockings on Limb Oxygenation and Venous Function during Exercise in Patients with Venous Insufficiency
  171. Potential role of endothelin 1 in ischaemia-induced angiogenesis in critical leg ischaemia
  172. The Early Effect of Lipid-lowering Treatment on Carotid and Femoral Intima Media Thickness (IMT)
  173. Endothelin Receptors in the Aetiology and Pathophysiology of Varicose Veins
  174. Vascular and Biology 01
  175. Catheter angiography and angioplasty in patients with scleroderma
  176. Endothelial integrity and nitric oxide synthase sources are better maintained in saphenous vein harvested by a ‘no-touch’ technique
  177. Deep Vein Thrombosis Prophylaxis: Audit of Practice in General Surgical Patients in a Teaching Hospital
  178. Deep Vein Thrombosis Prophylaxis: Audit of Practice in General Surgical Patients in a Teaching Hospital
  179. Decreased endothelin binding and receptor density in varicose veins
  180. Effect of stockings on calf muscle oxygenation in patients with venous insufficiency
  181. The tourniquet in total knee arthroplasty
  182. The tourniquet in total knee arthroplasty
  183. Graduated compression stockings in the prevention of venous thromboembolism
  184. Early results of endovascular aortic aneurysm surgery with aortouniiliac graft, contralateral iliac occlusion, and femorofemoral bypass
  185. Haemodynamic and metabolic response to endovascular repair of infra-renal aortic aneurysms
  186. Endovascular stenting of internal carotid artery false aneurysm
  187. Neurons and microvessels of the nodose (vagal sensory) ganglion in young adult and aged rats: morphometric and enzyme histochemical studies
  188. Randomized controlled trial of the effect of mannitol on renal reperfusion injury during aortic aneurysm surgery
  189. Assessment of wall structure and composition of varicose veins with reference to collagen, elastin and smooth muscle content
  190. Metabolic and renal effects of abdominal aortic anerusym repair using conventional and endovascular techniques
  191. Endoluminal transfemoral abdominal aortic aneurysm repair with aorto-uni-iliac graft and femorofemoral bypass
  192. How successful is varicose vein surgery? A patient outcome study following varicose vein surgery using the SF-36 health assessment questionnaire
  193. Infective popliteal aneurysm following Salmonella bacteraemia
  194. 19th Sir peter freyer memorial lecture and surgical symposium 16th and 17th September 1994
  195. Transfemoral endoluminal repair of abdominal aortic aneurysm with bifurcated graft
  196. Taurolidine peritoneal lavage as prophylaxis against infection after elective colorectal surgery
  197. Significant plain film findings in sigmoid volvulus
  198. Seventeenth Sir Peter Freyer memorial lecture and surgical symposium
  199. Endoscopic transthoracic sympathectomy as adjuvant treatment for critical upper-limb ischaemia
  200. New adjustable knot for securing subcuticular running sutures
  201. The sensitivity and specificity of the plain radiographic features of sigmoid volvulus
  202. Protective efficacy of BCG vaccine against leprosy in southern Malaŵi
  203. Return to work after inguinal hernia repair
  204. Vasectomy and prostate cancer: public health implications
  205. Non-steroidal anti-inflammatory drugs and appendicitis in patients aged over 50 years
  206. Mesosigmoplasty as a definitive operation for sigmoid volvulus
  207. Biochemical and Histological Analysis of Collagen and Elastin Content and Smooth Muscle Density in Normal and Varicose Veins
  208. General practice and accident and emergency department care: does the patient know best?
  209. BCG vaccine and leprosy
  210. Surgical management of the thoracic outlet compression syndrome
  211. Evidence for a decrease in sympathetic control of intestinal function in the aged rat
  212. Effect of age on the beta-adrenergic receptor population in the longitudinal muscle layer of the rat ileum
  213. Development of a quantitative histochemical method for determination of succinate dehydrogenase activity in autonomic neurons and its application to the study of aging in the autonomic nervous system.
  214. Morphometric studies on the microvasculature of pre- and paravertebral sympathetic ganglia in the adult and aged rat by light and electron microscopy
  215. Image analysis of the sympathetic innervation of the myenteric plexus in the small intestine of mammalian species
  216. Enteric neuron numbers and sizes in Auerbach's plexus in the small and large intestine of adult and aged rats
  217. A quantitative study of the effects of age on the noradrenergic innervation of Auerbach's plexus in the rat
  218. Morphometric studies on pre- and paravertebral sympathetic neurons in the rat: Changes with age
  219. Identifying Other Atherosclerotic Diseases
  220. The Significance Of Stroke
  221. Thyroid Diseases and Stroke
  222. Investigating Patients at Risk of Stroke
  223. Reducing Cervical Vessel Embolic Events
  224. Reducing Cardioembolic Events
  225. Managing Lacunar Infarcts
  226. Reducing the Risk of Stroke by Modifying Life Style
  227. Current State of Medical Therapies for Peripheral Vascular Disease
  228. Vascular Complications of Systemic Sclerosis: A Molecular Perspective
  229. Managing Hyperlipidemia
  230. Antiplatelet Therapy
  231. Managing Procoagulant Thrombotic States
  232. Managing Central Nervous System Vasculitis
  233. Identifying Patients at Risk of Ischemic Stroke
  234. Managing Stroke in Human Immunodeficiency Virus–Infected Patients
  235. Management of Silent Myocardial Ischemia in Stroke Patients
  236. Varicose Veins